Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2008
10/23/2008US20080261861 2-Micron Family Plasmid and Use Thereof
10/23/2008US20080261833 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
10/23/2008US20080261819 Providing plurality of cells comprising first and second interacting proteins and contacting cells with library of fusion nucleic acids, which nucleic acids comprise sequences encoding C-terminal and N-terminal intein motif and peptide; fusion proteins; libraries; monitoring ubiquitination
10/23/2008US20080261311 Translation systems with orthogonal aminoacyl tRNA synthetase; membrane proteins
10/23/2008US20080261304 Interfering RNA with cholesterol moieties linked
10/23/2008US20080261303 Method and medicament for inhibiting the expression of a given gene
10/23/2008US20080261302 Nucleotide sequences coding seladin-1polypeptide for use in treatment and prevention of alzheimer's disease
10/23/2008US20080261300 Expression vector comprising nucleotide sequences coding polyketide synthase for use in production of polyketide compounds
10/23/2008US20080261289 Compositions comprising viruses and methods for concentrating virus preparations
10/23/2008US20080261286 Methods for producing optically active alpha-hydroxy amides
10/23/2008US20080261281 Capable of asymmetrically reducing (3S)-1-chloro-3-tert-butoxycarbonylamino-4-phenyl-2-butanone to produce (2R,3S)-1-chloro-3-tert-butoxycarbonylamino-4-phenyl-2-butanol, isolated from Ogataea
10/23/2008US20080261280 Manipulation of Genes of the Mevalonate and Isoprenoid Pathways to Create Novel Traits in Transgenic Organisms
10/23/2008US20080261279 Method for producing l-amino acid using bacteria belonging to the genus escherichia
10/23/2008US20080261278 Transgenic gramnegative bacteria for use as bioreactor in for fermentation of arginine and/or proline for use in medicine, cosmetics and animal feeds
10/23/2008US20080261277 Circularly permuted RNA molecule carrying a stabilized biologically active RNA; antisense RNA; gene expression inhbition; ribozyme
10/23/2008US20080261275 Recovering and replicating RNA sequences from preferential tissues; organ specific RNA libraries
10/23/2008US20080261274 Restoration of Cholesterol Independence and Its Use as a Selectable Marker in Ns0 Cell Culture
10/23/2008US20080261273 PROCESS FOR PRODUCING HMG-CoA REDUCTASE INHIBITORS
10/23/2008US20080261272 reporter system reflecting the transport process that transports GPI-anchored proteins to the cell wall was constructed and compounds inhibiting this process were discovered; antifungal agents; inhibiting expression of cell wall glycoproteins and preventing pathogens from showing pathogenicity; DNA
10/23/2008US20080261271 Expression of hiv polypeptides and production of virus-like particles
10/23/2008US20080261270 Expression vector comprising nucleotide sequences estrogen receptor protein for use in inhibition of heregulin binding and treatment of breast and prostate cancers
10/23/2008US20080261269 Alleles of the oxyr gene from coryneform bacteria
10/23/2008US20080261268 5-Substituted Hydantoin Racemase, Dna Encoding the Same, Recombinant Dna, Transformed Cell, and Process for Production of Optically Active N-Carbamylamino Acid or Optically Active Amino Acid
10/23/2008US20080261267 Cellulases from Rumen
10/23/2008US20080261257 Fluorescent Proteins and Related Methods and Compounds
10/23/2008US20080261256 Methods of assaying receptor activity and constructs useful in such methods
10/23/2008US20080261252 Soluble Interleukin-1 Receptor Accessory Molecule
10/23/2008US20080261241 Targeted ubiquitination of proteins and screening methods using a new class of ubiquitin ligase proteins
10/23/2008US20080261228 Using prostate cancer antigen (PCA) expression as evaluative tool in diagnosis/prognosis of cancer
10/23/2008US20080261224 PGC-1Beta, A Novel PGC-1 Homologue and Uses Therefor
10/23/2008US20080261198 Hemagglutinin (HA) and/or neuraminidase (NA) specific primer for use in screening for influenza infection
10/23/2008US20080261197 O retroviral protein for use as tool in detection, treatment and prevention of human immunodeficiency virus infection
10/23/2008US20080260933 Certain Plants with "No Saturate" or Reduced Saturate Levels of Fatty Acids in Seeds, and Oil Derived from the Seeds
10/23/2008US20080260929 Endogenous seed oil having increased stearidonic acid content; transgenic plants, recombinant constructs, isolated polynucleotides
10/23/2008US20080260903 Phospholipase
10/23/2008US20080260854 Sirna Molecules for the Treatment of Blood Vessels
10/23/2008US20080260830 suitable for regeneration, growth stimulation and differentiation of various cells, tissues and organs; growth/differentiation factors (GDFs); regeneration of connective tissue including tendon and/or ligament, periodontal or dental tissue including dental implants, neural tissue and sensory tissues
10/23/2008US20080260812 Therapeutic Medicine Containing Monoclonal Antibody Against Folate Receptor Beta (Fr-Beta)
10/23/2008US20080260789 Expressed in venom glands of spiders; polynucleotides; transgenic plant or insect
10/23/2008US20080260780 Materials and methods relating to improved vaccination strategies
10/23/2008US20080260775 Modified Rna virus packaged with structural proteins and second virus; induce immunology response
10/23/2008US20080260767 Novel Protein Which can be Used, in Particular, for the In Vitro Isolation and Prevention of Legionella Pneumophila Infections
10/23/2008US20080260761 Compositions, Splice Variants and Methods Relating to Cancer Specific Genes and Proteins
10/23/2008US20080260759 Novel Mite Allergen
10/23/2008US20080260758 Cell which expresses granulocyte colony stimulating factor and is deficient in major histocompatibility class I (MHC-I) antigens and major histocompatibility class II (MHC-II) antigens and which stimulates immune response to cancer
10/23/2008US20080260755 Therapeutic fusion protein in which coagulation factor sequences are fused to half-life enhancing polypeptide for use in treatment of hemophilia
10/23/2008US20080260753 Transgenic animal model expressing NOD mutant for use in identifying modulator for treatment of inflammatory bowel disease
10/23/2008US20080260752 Prevention and reduction of blood loss
10/23/2008US20080260750 Polynucleotides Encoding Acetylcholine-Gated Chloride Channel Subunits of Caenorhabditis Elegans
10/23/2008US20080260748 Desmocollin 2 (DSC2) specific immunoglobulin for use in prevention and treatment of cell proliferative disorders
10/23/2008US20080260747 Adhesion interaction protein (CD-84) specific immunoglobulin for use in the treatment of cell proliferative disorders of the blood
10/23/2008US20080260743 Means and Methods for Detecting Methylated Dna
10/23/2008US20080260742 Preventives/Remedies for Cancer
10/23/2008US20080260741 Preventive and/or Therapeutic Agent for Cancer
10/23/2008US20080260738 Single chain fc, methods of making and methods of treatment
10/23/2008US20080260735 Glycoprotein-340 for use in targeted destruction of cancer tissues; immunotherapy
10/23/2008US20080260733 Humanized collagen antibodies and related methods
10/23/2008US20080260729 Using RNA interference and/or endothelial growth factor specific immunoglobulins to target, treat and prevent cell proliferative disorsders
10/23/2008US20080260726 Using cathepsin C gene expression as evaluative tool in identifying modulators for prevention and treatment of inflammatory or obstructive diseases of the respiratory system
10/23/2008US20080260725 Tag and target delivery system
10/23/2008US20080260721 Nucleotide sequences coding regulatory-associated protein of mTOR (Raptor) protein for use in identifying modulators for prevention and treatment of cancer and diabetes
10/23/2008US20080260718 Phospholipase C Gamma Modulation and Uses Thereof for Management of Pain and Nociception
10/23/2008US20080260717 Methods for Reducing Seizure-Induced Neuronal Damage
10/23/2008US20080260713 Neukinase, A Downstream protein of neuregulin
10/23/2008US20080260711 Detoxifizyme with Activity of Transforming Aflatoxin and the Gene Encodes Thereof
10/23/2008US20080260707 Isolated homozygous stem cells, differentiated cells derived therefrom and materials and methods for making and using same
10/23/2008US20080260706 Transient Transfection with RNA
10/23/2008US20080260693 Methods for producing and using in vivo pseudotyped retroviruses using envelope glycoproteins from lymphocytic choriomeningitis virus (lcmv)
10/23/2008US20080260646 Imaging Reporters of Transgene Expression
10/23/2008US20080260642 Fusion protein mixture containing bacteriophage specific protein and ligand; detection of target structures; peptide binding signal generating material
10/23/2008US20080260641 Isolated human monoclonal antibodies which bind to lymphocyte function associated antigens; therapy and diagnosis methods; skin disorders; antiarthritic agents; inflammatory bowel disease
10/23/2008CA2688693A1 Interferons of rhesus and cynomolgus origin and uses thereof
10/23/2008CA2684534A1 Constructs for enhancement of gene expression in muscle
10/23/2008CA2684494A1 Fusion protein vaccine
10/23/2008CA2684370A1 Mammalian-type glycosylation in plants by expression of non-mammalian glycosyltransferases
10/23/2008CA2683960A1 Methods of genetically encoding unnatural amino acids in eukaryotic cells using orthogonal trna/synthetase pairs
10/23/2008CA2683907A1 New modulating molecules for an improved regulated expression system
10/23/2008CA2683810A1 Pest control using a combination of insecticides and transgenic plants by means of leaf and drenching application
10/23/2008CA2683733A1 Method for improved utilization of the production potential of transgenic plants
10/23/2008CA2683562A1 Sirtuin based methods and compositions for treating .beta.-catenin-related conditions
10/23/2008CA2683469A1 Genetic suppression and replacement
10/23/2008CA2683454A1 Tem8 peptides and vaccines comprising the same
10/23/2008CA2683314A1 Isolated nucleic acid molecules corresponding to micro rna 145 (mirna-145) and their use in treating colon cancer
10/23/2008CA2682962A1 .delta.9 elongases and their use in making polyunsaturated fatty acids
10/23/2008CA2682350A1 Diagnosis and treatment of diseases caused by misfolded proteins
10/23/2008CA2682286A1 Polynucleotides for regulation of high level tissue-preferred expression in crop plants
10/23/2008CA2680739A1 Method for evaluation of tissue preservation solution
10/23/2008CA2679485A1 Delta-9 elongases and their use in making polyunsaturated fatty acids
10/23/2008CA2671540A1 Linear expression cassette vaccines
10/23/2008CA2665537A1 Dna-guided nanoparticle assemblies
10/23/2008CA2663523A1 Novel gene disruptions, compositions and methods relating thereto
10/23/2008CA2662701A1 Interleukin-13 binding proteins
10/23/2008CA2653988A1 Primer and probe sequences for detecting chlamydia trachomatis
10/23/2008CA2648864A1 Gene defects and mutant alk kinase in human solid tumors
10/22/2008EP1983059A2 Process for producing dipeptides
10/22/2008EP1983057A2 Improved AAV vectors for gene therapy
10/22/2008EP1983056A1 Method for transforming monocotyledons
10/22/2008EP1983055A1 Albumin fusion proteins
10/22/2008EP1983054A1 Carbonic anhydrase and methods using the same
10/22/2008EP1983053A2 Cell distribution control for cells within bioartifical organs
1 ... 1329 1330 1331 1332 1333 1334 1335 1336 1337 1338 1339 1340 1341 1342 1343 1344 1345 1346 1347 1348 1349 ... 4023